Cypron en es it fr

Cypron Brand names, Cypron Analogs

Cypron Brand Names Mixture

  • No information avaliable

Cypron Chemical_Formula


Cypron RX_link

No information avaliable

Cypron fda sheet

Cypron msds (material safety sheet)

Cypron Synthesis Reference

No information avaliable

Cypron Molecular Weight

309.469 g/mol

Cypron Melting Point

< 25 oC

Cypron H2O Solubility

Soluble as HCl salt

Cypron State


Cypron LogP


Cypron Dosage Forms

Tablets (oral, 1 mg)

Cypron Indication

Used for the symptomatic treatment of parkinsonism.

Cypron Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Cypron Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Cypron side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Cypron Patient Information

Cypron Organisms Affected

Humans and other mammals